Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices 20477

1237; telephone (301) 734–8400; fax

(301) 734–8910.

SUPPLEMENTARY INFORMATION: A

veterinary biological product regulated

under the Virus-Serum-Toxin Act (21

U.S.C. 151 et seq.) must be shown to be

pure, safe, potent, and efficacious before

a veterinary biological product license

may be issued. The regulations in 9 CFR

part 102 regarding the licensing of

biological products provide that a

conditional veterinary biological

product license may be issued to meet

an emergency situation, limited market,

local situation, or other special

circumstance. The special circumstance

addressed here is the current raccoon

rabies epizootic in the United States.

The product being issued a conditional

license is intended for vaccinating

raccoons against rabies. No other

licensed product is currently available

for this purpose. The vaccination of

raccoons is proposed to limit the further

spread of the raccoon rabies epizootic,

and to prevent the spread of rabies to

domestic animals and to humans.

Conditionally licensed products are

required to be pure and safe, and have

a reasonable expectation of efficacy.

In determining whether to issue a

conditional license for the veterinary

biological product referenced in this

notice, the Animal and Plant Health

Inspection Service (APHIS) conducted a

risk analysis to assess the product’s

potential effects on the safety of

animals, public health, and the

environment. Based on that risk

analysis, APHIS has prepared an

environmental assessment. APHIS has

concluded that issuance of a conditional

veterinary biological product license for

the veterinary biological product

referenced in this notice will not

significantly affect the quality of the

human environment. Based on the

finding of no significant impact, we

have determined that there is no need

to prepare an environmental impact

statement.

An environmental assessment and a

finding of no significant impact have

been prepared for the issuance of a

conditional veterinary biological

product license for the following

veterinary biological product: Rabies

Vaccine, Live Vaccinia Vector; Code

1901.R0; to be issued to Rhone Merieux,

Inc., Establishment License No. 298.

This recombinant rabies vaccine is

intended for vaccinating raccoons

against rabies, and is not intended for

use in pets. The conditional license

restricts the use of this product to State

or Federal Government agencies

administering wildlife rabies control

programs. The availability of the

recombinant rabies vaccine for use in

rabies control programs may be useful

in limiting the spread of the current

rabies epizootic in the United States.

A conditional license has been issued

on the basis that the product has been

demonstrated to be pure and safe, and

to have a reasonable expectation of

efficacy. The product has not met the

efficacy requirements of title 9, Code of

Federal Regulations, § 113.312 for rabies

vaccines; however, a reasonable

expectation of efficacy has been

demonstrated in the studies that have

been conducted to date. The efficacy of

this recombinant rabies vaccine will be

further evaluated during the conditional

license period. The State and Federal

Government agencies using the rabies

vaccine will be provided with detailed

instructions for safely using the

recombinant vaccine. These instructions

include continued use of the following

mitigative procedures that have been

implemented for the field tests

previously conducted with this product:

1. Public education efforts, including

education efforts directed at school-aged

children, should be conducted prior to

distributing the baits containing the

recombinant rabies vaccine. Warning

labels should be attached to the baits to

minimize the possibility of accidental

exposure of members of the local

populations in the areas where the

vaccine-laden baits are distributed. The

warning labels should clearly identify

the recombinant vaccine and list the

phone number for the local public

health authorities. The public education

efforts should be conducted prior to

distributing the baits and should

include newspaper articles, local

television reports, and the distribution

of brochures and posters. Public

information meetings may also be used.

In addition, when the baits are

distributed, signs should be posted at

the periphery and at strategic points

within the distribution area notifying

visitors of the rabies control efforts and

warning them not to disturb the

vaccine-laden baits.

2. The local public health authorities

in the areas where the recombinant

rabies vaccine is used should be notified

prior to the distribution of the baits. The

public health authorities should be

instructed to inform the authorizing

State or Federal Government agency of

any reported human contacts with the

vaccine-laden baits. Individuals who

may have been exposed to the vaccine

should be examined for any adverse

reactions or clinical signs of

orthopoxvirus infection, and have blood

samples drawn and analyzed for the

presence of antibodies of rabies and/or

vaccinia.

3. The personnel conducting the

rabies control programs should be

trained in the appropriate precautions

and techniques for assembling,

handling, and distributing the vaccineladen baits. These personnel should be

encouraged to be vaccinated against

vaccinia, as recommended by the U.S.

Public Health Service [Morbidity and

Mortality Weekly Report;

Recommendations and Reports;

Vaccinia (Smallpox) Vaccine,

Recommendations of the Immunization

Practices Advisory Committee (ACIP),

Vol. 40, pp. 1–10 (1991)], and also be

vaccinated against rabies. All personnel

should be non-pregnant adults at least

18 years of age, who are free of any

known immunosuppressive conditions.

Regular blood samples should be

collected from the personnel and

monitored for the presence of rabies and

vaccinia antibodies.

4. The filling of the liquid vaccine

into ampules for assembly into the baits

should be conducted according to

Biosafety Level-2 (BL–2) criteria [CDC–

NIH Manual: Biosafety in

Microbiological and Biomedical

Laboratories, Third Edition (1993) pp.

18–24].

5. Any adverse reactions observed in

the areas where the recombinant rabies

vaccine is used should be reported to

the licensed manufacturer, who will

forward this information to Veterinary

Biologics, APHIDS.

The environmental assessment and

finding of no significant impact have

been prepared in accordance with: (1)

The National Environmental Policy Act

of 1969 (NEPA) (42 U.S.C. 4321 et seq.),

(2) Regulations of the Council on

Environmental Quality for

Implementing the Procedural Provisions

of NEPA (40 CFR parts 1500–1508), (3)

USDA Regulations Implementing NEPA

(7 CFR part 1b), and (4) APHIS NEPA

Implementing Procedures (60 FR 6000–

6005, February 1, 1995).

Done in Washington, DC, this 20th day of

April 1995.

Lonnie J. King,

Acting Administrator, Animal and Plant

Health Inspection Service.

[FR Doc. 95–10241 Filed 4–25–95; 8:45 am]

BILLING CODE 3410–34–M
20478 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices

DEPARTMENT OF COMMERCE

International Trade Administration

[A–307–701, C–307–702]

Certain Electrical Conductor Aluminum

Redraw Rod From Venezuela; Notice of

Final Court Decision and Revocation of

Antidumping and Countervailing Duty

Orders

AGENCY: Import Administration,

International Trade Administration,

Department of Commerce.

ACTION: Notice of final court decision

and revocation of antidumping and

countervailing duty orders.

SUMMARY: On February 17, 1995, the

U.S. Court of Appeals for the Federal

Circuit (Federal Circuit) affirmed the

International Trade Commission’s (ITC)

determination on remand that an

industry in the United States was not

threatened with material injury by

reason of imports of certain electrical

conductor aluminum redraw rod (EC

rod). On March 1, 1995, the ITC

published notice in the Federal Register

of the final Federal Circuit decision

affirming its negative remand

determination (60 FR 11110). Therefore,

we are revoking the antidumping and

countervailing duty orders on EC rod

from Venezuela.

EFFECTIVE DATE: April 26, 1995.

FOR FURTHER INFORMATION CONTACT:

Brian Albright or Kelly Parkhill, Office

of Countervailing Compliance, Import

Administration, International Trade

Administration, U.S. Department of

Commerce, 14th Street and Constitution

Avenue, NW., Washington, DC. 20230;

telephone: (202) 482–5253.

SUPPLEMENTARY INFORMATION:

Background

On June 30, 1988, the Department of

Commerce (the Department) determined

that EC rod from Venezuela was being

subsidized and sold at less than fair

value (53 FR 24755, 24763). On August

17, 1988, the ITC determined that a U.S.

industry was threatened with material

injury by reason of imports of EC rod

from Venezuela (53 FR 31111). On

August 22, 1988, the Department

published in the Federal Register the

antidumping and countervailing duty

orders on EC rod from Venezuela (53 FR

31903, 31904).

Suramerica de Aleaciones Laminadas,

C.A., a Venezuelan exporter of EC rod,

and others, appealed the ITC

determination in the Court of

International Trade (CIT). On March 15,

1993, the CIT reversed and remanded

the ITC’s original determination. On

June 2, 1993, the ITC determined on

remand that there was no threat of

material injury to a U.S. industry. This

remand was affirmed by the CIT on

August 4, 1993. Suramerica de

Aleaciones Laminadas, C.A. v. United

States, 841 F. Supp. 1220 (CIT 1993).

The ITC and petitioner Southwire,

Inc., appealed the CIT’s decision to the

Federal Circuit. On December 30, 1994,

the CIT’s decision was affirmed by the

Federal Circuit. Suramerica v. United

States, Nos. 93–1579 and 94–1021 (Fed.

Cir. Dec. 30, 1994). Southwire filed in

the Federal Circuit a petition for

rehearing and suggestion for rehearing

in banc. On February 13, 1995, the

Federal Circuit denied Southwire’s

petition for rehearing and declined the

suggestion for a rehearing in banc. On

March 1, 1995, the ITC published notice

in the Federal Register of the final

Federal Circuit decision affirming its

negative remand determination.

As a result of the ITC notification that

there is no threat of material injury to

the U.S. industry, the Department is

revoking the antidumping and

countervailing duty orders on EC rod

from Venezuela. On October 12, 1993

(58 FR 52744), in accordance with

Timken Co. v. United States, 893 F.2d

337 (Fed. Cir. 1990), the Department

stated that, effective August 14, 1993, it

would continue the suspension of

liquidation on the subject merchandise

until the Federal Circuit issued a

conclusive decision in this lawsuit.

Therefore, revocation of these orders is

effective August 14, 1993, for all

unliquidated entries.

Scope of Order

Imports covered by these orders are

shipments of certain electrical

conductor aluminum redraw rod from

Venezuela, which is wrought rod of

aluminum that is electrically conductive

and contains not less than 99 percent

aluminum by weight. This merchandise

is currently classifiable under item

numbers 7604.10.3010, 7604.10.3050,

7604.29.3010, 7604.29.3050,

7605.11.0030, 7605.11.0090,

7605.19.0000, 7605.21.0030,

7605.21.0090 and 7605.29.0000 of the

Harmonized Tariff Schedule (HTS). The

HTS item numbers are provided for

convenience and Customs purposes.

The written description remains

dispositive.

Termination of Suspension of

Liquidation

Pursuant to section 516(e)(2) of the

Tariff Act of 1930, as amended, the

Department will instruct the U.S.

Customs service to terminate the

suspension of liquidation of EC rod

from Venezuela and proceed with

liquidation of the subject merchandise,

which entered the United States on or

after August 14, 1993, without regard to

antidumping or countervailing duties.

Dated: April 19, 1995.

Joseph A. Spetrini,

Deputy Assistant Secretary for Compliance.

[FR Doc. 95–10264 Filed 4–25–95; 8:45 am]

BILLING CODE 3510–DS–P

[C–351–029]

Final Results of Countervailing Duty

Administrative Review: Certain Castor

Oil Products From Brasil

AGENCY: Import Administration,

International Trade Administration,

Department of Commerce.

EFFECTIVE DATE: April 26, 1995.

FOR FURTHER INFORMATION CONTACT:

Vincent Kane or Cynthia Thirumalai,

Office of Countervailing Investigations,

Import Administration, U.S. Department

of Commerce, Room B099, 14th Street

and Constitution Avenue NW.,

Washington, DC 20230; telephone (202)

482–2815 and (202) 482–4087,

respectively.

Final Determination

Background

On November 7, 1994, the Department

of Commerce (the Department)

published in the Federal Register (59

FR 55443) the preliminary results of its

administrative review of the

countervailing duty order on certain

castor oil products from Brazil

(Preliminary Determination). See 41 FR

11018 (March 16, 1976). The

Department has now completed that

administrative review in accordance

with section 751 of the Tariff Act of

1930, as amended (the Act).

Applicable Statute and Regulations

The Department is conducting this

administrative review in accordance

with section 751(a) of the Act. Unless

otherwise indicated, all citations to the

statute and to the Department’s

regulations are in reference to the

provisions as they existed on December

31, 1994.

Scope of Review

The merchandise subject to this

review is hydrogenated castor oil and

12-hydroxystearic acid. Imports of these

products are currently classifiable under

the following Harmonized Tariff

Schedule (‘‘HTS’’) subheadings:

1516.20.90 and 1519.19.40. Although

the HTS subheadings are provided for

convenience and customs purposes, our